WuXi Biologics ("WuXi Bio"), a leading global open-access biologics technology platform company offering end-to-en...
ACell, a leading regenerative medicine company has entered into an exclusive long-term product supply and distribution a...
A fully integrated biopharmaceutical company Uni-Bio Science Group Limited has announced the appointment of Mr...
Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for can...
Hope Medicine has signed a world-wide exclusive license agreement with Bayer AG on the development and commercialization...
I-Mab Biopharma (I-Mab), a clinical stage biotech company based in Shanghai with an exclusive focus on the dev...
China Maternal and Child Health Care Association and Wuhan University Landing AI Cytology Diagnostic Center launched&nbs...
The Cervical Cancer Screening Management System (CCSMS) developed by the Hong Kong Applied Science and Technology Resear...
Sinovant Sciences and Roivant Sciences have announced the launch of Cytovant Sciences, a biopharmaceutical company focus...
Ally Bridge Group (ABG), a leading cross-border life science investment group, has entered into an agreement with LifeTe...
ITM Isotopen Technologien München AG (ITM), a group of specialized radiopharmaceutical companies and United Imaging...
Aptorum Group Limited has announced the appointment of Dr. Thomas Wai-yip Lee as Head of Research and Development and Dr...
Novartis, a global leader in immuno-dermatology and rheumatology, has announced that the China Health Authority NMPA app...
Merck, known as MSD outside the United States and Canada, has announced that KEYTRUDA, Merck’s anti-PD-1 therapy, ...
As a high-end conference and event week specially launched concurrently with CPhI China, organized by UBM EMEA, CCCMHPIE...
WuXi NextCODE, a global genomic data and insights company, is expanding its laboratory footprint into the U.S. with the ...
AstraZeneca is spearheading the creation of a new life sciences park, in Wuxi, China, that aims to nurture innovation by...
Luye Pharma Group has announced submission of a new drug application (NDA) to the U.S. Food and Drug Administration for ...
